Category: Drugs (Pharmaceuticals)

Trump Promotes Program to Reduce Medicaid Drug Prices

The New York Times – Business:
Ahead of the midterm elections, the president said that all states had opted in to an effort to align Medicaid’s prices for medicines with those in other wealthy countries.
Use of GLP-1s Like Ozempic Is Forcing Food Companies to Adapt

The New York Times – Business:
People on medications for weight loss are buying less food, shrinking their portion sizes and purchasing smaller clothes. Businesses are trying to adjust.
The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists

The New York Times – Business:
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future

The New York Times – Business:
Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

The New York Times – Business:
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
Walmart to Pay $50 Million to Settle Opioid Lawsuit, US Says

The New York Times – Business:
The resolution is part of an effort to hold retailers and pharmacists accountable for what the government says were their roles in the opioid epidemic.
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many

The New York Times – Business:
Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

The New York Times – Business:
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Moderna’s Shift to Cancer Company Lifts Stock Up 177%

The New York Times – Business:
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Can We Do Anything About Tick-Borne Diseases Like Alpha-Gal Syndrome?

The New York Times – Business:
A scientific and civilizational horror story.
How One Woman With a Very Rare Disease Secured a Clinical Trial

The New York Times – On the Runway:
Through sheer determination, Neena Nizar has become the first patient in a clinical trial testing a treatment for her disease — one so rare it affects just 30 people worldwide.
A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease

The New York Times – Business:
The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease.